MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: To investigate the role of depletion or excess of various heavy metals on clinical characteristics of Parkinson's disease (PD) developing PD dementia in drug-naïve…
  • 2023 International Congress

    Intercultural differences in patient and clinician perceptions of MDS-UPDRS in Parkinson’s disease

    V. Kaasinen, S. Luo, P. Martinez-Martin, C. Goetz, G. Stebbins (Turku, Finland)

    Objective: To explore culturally dependent differences between patient- and clinician-based evaluations of Parkinson’s disease (PD) motor symptoms. Background: Effects of multiple demographic factors on Movement…
  • 2023 International Congress

    NLX-112 has favorable safety and tolerability and displays efficacy against levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD)

    P. Svenningsson, P. Odin, F. Berquist, K. Wirdefeldt, D. Nyholm, M. Andréasson, I. Markaki, A. Johansson, M. Jergil, C. Jankosky, M. Varney, F. Herbrecht, S. Johnson, A. Newman-Tancredi (Solna, Sweden)

    Objective: To assess the safety, tolerability and preliminary efficacy of NLX-112 (a.k.a. befiradol) in patients with moderate to severe LID in PD: a randomized, double-blind,…
  • 2023 International Congress

    Visuo-spatial processing is linked to cortical glutamate dynamics in Parkinson’s disease – a 7 Tesla functional MRS study

    A. Ophey, E. Farrher, N. Pagel, A. Seger, C. Doppler, N. Shah, E. Kalbe, G. Fink, M. Sommerauer (Cologne, Germany)

    Objective: To investigate alterations of glutamate metabolism in the occipital cortex during visual processing in patients with Parkinson’s disease (PD). Background: Cognitive decline is a…
  • 2023 International Congress

    The changes in alpha-synuclein level and oscillatory activity of substantia nigra by nigral electrical stimulation

    T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kwabara (Chiba, Japan)

    Objective: We aimed to clarify the relationships between the alpha-synuclein level and abnormal oscillatory activity and their changes induced by deep brain stimulation of the…
  • 2023 International Congress

    Management of constipation in Parkinson’s patients presenting with acute sigmoid volvulus to Royal Berkshire Hospital,Reading, UK

    M. Khwaja, S. Alam, E. Castaneda-Caicedo, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate management of constipation in acute sigmoid volvulus in Parkinson’s. Background: Constipation is one of the main and disabling non motor symptoms in…
  • 2023 International Congress

    Genome Wide Association Studies using TRACTOR reveals new associated loci with Parkinson Disease in a Latino Cohort

    T. Leal, V. Borda, M. Gouveia, M. Inca-Martinez, E. Mason, D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Sarapura-Castro, A. Rivera-Valdivia, A. Medina, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, S. Moreno, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Cleveland, USA)

    Objective: Our objective was using TRACTOR[1], which performs Genome Wide Association Study (GWAS) including Local Ancestry (LA) information, in Parkinson Disease (PD) using data from…
  • 2023 International Congress

    Plasma glucosylsphingosine in GBA1 E326K, N370S and L444P mutation carriers with and without Parkinson’s disease

    A. Haimovich, J. Agin-Liebes, N. Hatcher, L. Yao, C. Waters, R. Alcalay (New York, USA)

    Objective: To measure plasma glucosylsphingosine levels in heterozygous carriers with and without Parkinson's disease (PD) of three variants in GBA1: 1. E326K (risk factor for…
  • 2023 International Congress

    A validation study of the Mini-BESTest in a Spanish population with Parkinson’s disease.

    A. García Bustillo, F. Valiñas Sieiro, M. Allende Río, A. Olivares Gil, JL. Garrido Labrador, JM. Ramírez Sanz, M. Jahouh, A. Arnaiz González, JF. Díez Pastor, N. Mariscal, S. Calvo Simal, J. Rivadeneyra-Posadas, L. Simón Vicente, J. González Santos, JJ. González Bernal, JM. Gabriel Galán, E. Cubo (Burgos, Spain)

    Objective: Because the Mini Balance Evaluation Systems Test (Mini-BESTest) is widely used, our aim was to validate the Spanish version in PD. Background: Parkinson's disease…
  • 2023 International Congress

    refractory myoclonus after COVID-19 with resolution after corticosteroids; a case report with brain biopsy and serial neuroimaging.

    E. Marandi, M. Gates, H. Patel, P. Hanna, W. Ma (Edison, USA)

    Objective: To present an individual with multifocal myoclonus after COVID-19 infection with resolution of bilateral MRI hyperintensities following corticosteroids use. Background: Myoclonus after Covid-19 infection…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley